Unveiling the role of particulate matter (PM) and micro-/nanoplastic (MNP) in glomerular kidney disease with focus on membranous glomerulonephritis (Acronym: UNPLOK)
揭示颗粒物 (PM) 和微/纳米塑料 (MNP) 在肾小球肾病中的作用,重点关注膜性肾小球肾炎(缩写:UNPLOK)
基本信息
- 批准号:523847126
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:
- 资助国家:德国
- 起止时间:
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Membranous glomerulonephritis (MGN) is caused by autoantibodies (AABs) binding to podocyte antigens. The most frequent AAB is LA2R antibody. However, it remains unknown what triggers AAB production and how ABBs reach the subepithelial space in MGN, because the glomerular filtration barrier (GFB) is normally almost impermeable for AABs. In the past, we could show that podocyte and glomerular endothelial cell derived microRNAs (miRs) that target nephronectin - an extracellular matrix protein of the GBM produced by podocytes - might play a role in MGN. We hypothesize that particulate matter (PM) or Micro-/ nanoplastic (MNP) induce miRs that target GBM molecules enabling AABs to reach the subpodocyte space and inhibit autophagy in MGN. This hypothesis should be tested in three dimensional glomerular cell culture models, transgenic zebrafish models and mice including proteinuria and autophagy reporter lines, inducible podocyte specific miR overexpressing lines and transgenic Pla2r mice. Cell culture models as well as zebrafish and mice will be exposed to PM and MNP via cell culture medium, water and versatile aerosol concentration enrichment system. The therapeutic potential of miR antagomirs should be investigated in our zebrafish model after PM/ MNP exposure. Samples will be analyzed using miR/ mRNA arrays, Western Blot, proteinuria and autophagy assays together with a unique combination of multi-modal, scale-bridging analytics such as Raman spectroscopy, nanoGPS technology, scanning electron- and ion microscopies (FIB/SEM) and scanning ion conductance microscopy (SCICM). Kidney biopsies of patients with MGN will also be included. The comprehensive data will be correlated, quantitatively evaluated with statistical and machine learning methods and might predict future clinical diagnostic and therapeutic options.
膜性肾小球肾炎(MGN)是由自身抗体(AAB)结合足细胞抗原引起的。最常见的AAB是LA 2 R抗体。然而,它仍然是未知的触发AAB的生产和ABBs如何到达上皮下空间在MGN,因为肾小球滤过屏障(GFB)通常是几乎不可渗透的AAB。在过去,我们可以表明,足细胞和肾小球内皮细胞衍生的microRNA(miR),靶向肾连蛋白-足细胞产生的GBM的细胞外基质蛋白-可能在MGN中发挥作用。我们假设颗粒物质(PM)或微/纳米塑料(MNP)诱导靶向GBM分子的miR,使AAB能够到达足细胞下空间并抑制MGN中的自噬。这一假设应在三维肾小球细胞培养模型、转基因斑马鱼模型和小鼠(包括蛋白尿和自噬报告细胞系、可诱导足细胞特异性miR过表达细胞系和转基因Pla 2 r小鼠)中进行检验。细胞培养模型以及斑马鱼和小鼠将通过细胞培养基、水和多功能气溶胶浓度富集系统暴露于PM和MNP。应在PM/ MNP暴露后在我们的斑马鱼模型中研究miR-1200的治疗潜力。将使用miR/ mRNA阵列、蛋白质印迹、蛋白尿和自噬试验以及多模态、尺度桥接分析的独特组合(如拉曼光谱、nanoGPS技术、扫描电子和离子显微镜(FIB/SEM)和扫描离子电导显微镜(SCICM))分析样本。还将纳入MGN患者的肾活检。综合数据将被关联,并通过统计和机器学习方法进行定量评估,并可能预测未来的临床诊断和治疗选择。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professorin Dr.-Ing. Silke Christiansen其他文献
Professorin Dr.-Ing. Silke Christiansen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professorin Dr.-Ing. Silke Christiansen', 18)}}的其他基金
Group-III-nitride nanowires: electrical and optical properties in view of applications in solarcells
III族氮化物纳米线:考虑到太阳能电池应用的电学和光学特性
- 批准号:
213632685 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Research Units
Vertical, strained 1 D silicon Nanostructures and Devices
垂直应变一维硅纳米结构和器件
- 批准号:
5439632 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Research Grants
Defect and interfacial characterization of SiC wafers, structures and devices based on electron microscope techniques
基于电子显微镜技术的 SiC 晶圆、结构和器件的缺陷和界面表征
- 批准号:
5368708 - 财政年份:2002
- 资助金额:
-- - 项目类别:
Research Units
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
- 批准号:82371070
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Particulate exposure and kidney health: Diversity Supplement Villarreal Hernandez
颗粒物暴露与肾脏健康:多样性补充剂 Villarreal Hernandez
- 批准号:
10770032 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Diversity Supplement to Microvascular mechanisms of growth restriction after environmental toxicant exposure (R01ES031285)
环境毒物暴露后生长受限的微血管机制的多样性补充(R01ES031285)
- 批准号:
10849145 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity.
空气污染介导的肥胖加剧中的肾素-血管紧张素系统。
- 批准号:
10654124 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Household Air Pollution, Adiposity, and Cardiorenal Disease Risk in Children
家庭空气污染、肥胖和儿童心肾疾病风险
- 批准号:
10739062 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Integrated exposome profiling to identify environmental risk factors of metabolic disease in mid- and late-life
综合暴露组分析可识别中晚年代谢疾病的环境危险因素
- 批准号:
10638457 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD
气道基础祖细胞功能障碍在早期 COPD 的检测、进展和发病机制中的作用
- 批准号:
10737267 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
- 批准号:
10718104 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Elucidating the functional mechanism of NLRP3 inflammasome activation
阐明NLRP3炎症小体激活的功能机制
- 批准号:
10720435 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck
个体化疫苗免疫疗法联合抗 PD 1 抗体治疗复发性或转移性头颈部鳞状细胞癌
- 批准号:
10658577 - 财政年份:2023
- 资助金额:
-- - 项目类别: